• ≡ İ
  • ≡ CHCAM
  • Ѷ
  • Shuzheng Health
  • Homepage
  • »
  • Whyth increase its investment by $ 5.85 Million
  • Back
  • WHAT OUR CLIENTS SAY
  • "Shuzheng surpassed my expectations and took a genuine " --Tongrentang
  • "We sincerely apprec-iate the professional and courteous manner " --Jameison
  • Whyth increase its investment by $ 5.85 Million
  • Jan.04,2008-(Shuzheng)-As one of leading pharmaceutical and health food (dietary supplements) Company, Whyth increase its investment by $ 5.85 Million (about RMB 0.44 billion) in China Mainland, which will be use...
  • 2008-01-04
  • Jan.04,2008-(Shuzheng)-As one of leading pharmaceutical and health food (dietary supplements) Company, Whyth increase its investment by $ 5.85 Million (about RMB 0.44 billion) in China Mainland, which will be used to enlarge the productive capability for Consumptive health food products as Centrum and Caltrate series in Whyth Suzhou Pharmaceutical Factory. It is expected that the productive capability will be reach 3.2 billion tablet from currently 1.6 billion tablet annually after the fulfill of this project.

     

    According to Wang Jue, director of Market Investigation Center of China Health Care Association Health Food Committee, it shows a repaid progress for Whyth in China, which makes them give priority to the Vitamin market here. Currently, Whyth promotes new product, called Centrum Jiawei Tablet. Photos as follow:

     

     

     

     

  • Ѷ
  • Shuzheng Health
  • HomePrivacy PolicyTerm of UsesLinks© 2017 Shuzheng Health (Beijing) Commercial Consultation Co., Ltd.